GABELLI & Co INVESTMENT ADVISERS INC. Acquires Shares of 2,000 The Clorox Company (NYSE:CLX)

GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,000 shares of the company's stock, valued at approximately $325,000.

Several other institutional investors have also modified their holdings of the company. Integral Investment Advisors Inc. raised its holdings in Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock worth $279,000 after buying an additional 67 shares during the period. HCR Wealth Advisors grew its holdings in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after buying an additional 68 shares in the last quarter. Sound View Wealth Advisors Group LLC raised its position in Clorox by 6.1% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock valued at $218,000 after buying an additional 77 shares during the period. Wedbush Securities Inc. increased its holdings in shares of Clorox by 1.2% in the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock valued at $1,238,000 after purchasing an additional 94 shares during the period. Finally, Brooklyn Investment Group lifted its position in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

CLX stock traded up $2.80 during trading hours on Friday, hitting $139.60. 948,624 shares of the stock were exchanged, compared to its average volume of 1,304,252. The firm has a market capitalization of $17.20 billion, a P/E ratio of 38.14, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a 50-day simple moving average of $146.57 and a two-hundred day simple moving average of $156.40. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 earnings per share. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.50%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research reports. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Evercore ISI increased their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. UBS Group reduced their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday. Finally, JPMorgan Chase & Co. decreased their target price on Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a research note on Friday, April 11th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $153.83.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.